In this study, we performed the in vivo CRISPR loss-of-function screening in lung cancer cells with sgRNA targeting 1685 metabolic enzymes and identified that aldehyde dehydrogenase 1 family member B1 (ALDH1B1) is required for tumor cell survival in confining capillaries. This evidence concerns the gene ALDH1B1 and lung carcinoma.